102 filings
8-K
KDNY
Chinook Therapeutics Inc
11 Aug 23
Termination of a Material Definitive Agreement
4:31pm
8-K
KDNY
Chinook Therapeutics Inc
3 Aug 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
KDNY
Chinook Therapeutics Inc
28 Jul 23
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy
8:15am
8-K
KDNY
Chinook Therapeutics Inc
20 Jun 23
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days
9:00am
8-K
KDNY
Chinook Therapeutics Inc
15 Jun 23
Departure of Directors or Certain Officers
4:17pm
8-K
dobmdj
12 Jun 23
Other Events
4:28pm
8-K
0s15yari44m5bn7ip
12 Jun 23
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
7:00am
8-K
c812rwpo43 99v3aomq
9 May 23
Chinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updates
4:03pm
8-K
mqazf3k5k2b33k6ug3
13 Apr 23
Chinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors
4:32pm
8-K
s0vhe
10 Mar 23
Regulation FD Disclosure
7:24pm
8-K
ygm6g
27 Feb 23
Chinook Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
4:04pm
8-K
7epuw287dqzgul2
24 Feb 23
Amendments to Articles of Incorporation or Bylaws
5:24pm
8-K
r8ttv0h
10 Nov 22
Chinook Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:03pm
8-K
wc6ghufqcr
8 Aug 22
Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
4:04pm
8-K
r6o3 5to7crc8
2 Jun 22
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
dlmth5pt
25 May 22
Chinook Therapeutics Announces Pricing of a $105 Million Public Offering
4:09pm
8-K
q302hu2i7s0jocpgxf
20 May 22
Regulation FD Disclosure
4:11pm
8-K
kup7mlk3xouvoc f7gx
12 May 22
Chinook Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results
4:07pm
8-K
h7m49kdky69ie5h31h
21 Mar 22
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
4:48pm
8-K
sqo0 eqojq
17 Mar 22
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:03pm